novartis
hits
acquisition
trail
swiss
drugmaker
novartis
announced
bn
euros
bn
â£bn
purchases
make
sandoz
unit
worlds
biggest
generic
drug
producer
novartis
last
month
forecast
record
sales
said
bought
germanys
hexal
also
acquired
hexals
us
affiliate
eon
labs
offered
buy
remaining
shares
novartis
said
would
able
make
cost
savings
year
following
acquisitions
novartis
shares
rose
swiss
francs
early
trading
deal
see
novartis
sandoz
business
overtake
israels
teva
pharmaceuticals
worlds
biggest
maker
generics
based
figures
newly
merged
producer
would
sales
bn
company
estimated
novartis
said
would
merge
number
departments
adding
may
job
cuts
strong
growth
outlook
sandoz
create
jobs
expected
partially
compensate
necessary
reductions
work
force
firm
said
statement
generic
drugs
chemically
identical
expensive
branded
rivals
producers
sandoz
copy
branded
products
usually
patent
protection
expires
sell
cheaply
pay
research
development
cost
generic
drugmakers
worldwide
analysts
predicted
consolidation
market
call
fragmented
however
analysts
initially
convinced
deal
expensive
acquisition
birgit
kuhlhoff
sal
oppenheim
investment
bank
told
reuters
find
strange
making
acquisitions
exactly
markets
suffered
price
pressure
